Global Blood Therapeutics (GBT) – PRNewswire
-
Guerbet to Spotlight the Novel New Drug Elucirem™ (gadopiclenol) injection at the 2022 Radiological Society of North America Scientific Assembly and Annual Meeting
-
Gadopiclenol Marketing Authorization dossier submissions accepted for review by EMA and FDA
-
Guerbet expands portfolio with microcatheters and guidewires for interventional imaging and embolization
-
Guerbet Announces Appointment of Jared Houk as Commercial Vice President for North America
-
Guerbet and Bracco Imaging Announce a Global Strategic Collaboration Agreement for Gadopiclenol
-
GBT Supports the ASH Research Collaborative's Data Hub Sickle Cell Disease Program
-
Guerbet Announces Appointment of Thomas McLaughlin as Vice President for North America
Back to GBT Stock Lookup
